相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。KRAS Mutation Status and Clinical Outcome of Preoperative Chemoradiation With Cetuximab in Locally Advanced Rectal Cancer: A Pooled Analysis of 2 Phase II Trials
Sun Young Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2012)
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Xiaoyun Liao et al.
CLINICAL CANCER RESEARCH (2012)
BRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis
Matthew F. Kalady et al.
DISEASES OF THE COLON & RECTUM (2012)
Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma
L. C. Krol et al.
EUROPEAN JOURNAL OF CANCER (2012)
Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients
I. Rako et al.
NEOPLASMA (2012)
PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis
Arantza Farina Sarasqueta et al.
CELLULAR ONCOLOGY (2011)
The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
Anna M. Dahlin et al.
CLINICAL CANCER RESEARCH (2010)
Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab
Jolien Tol et al.
EUROPEAN JOURNAL OF CANCER (2010)
Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma
Ki-Seok Jang et al.
HISTOPATHOLOGY (2010)
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Alberto Bardelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
F. Perrone et al.
ANNALS OF ONCOLOGY (2009)
A Prospective Cohort Study Shows Unique Epigenetic, Genetic, and Prognostic Features of Synchronous Colorectal Cancers
Katsuhiko Nosho et al.
GASTROENTEROLOGY (2009)
PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
Shuji Ogino et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer
Salvatore Siena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer
Andrea Sartore-Bianchi et al.
PLOS ONE (2009)
Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival
Hirozumi Sawai et al.
BMC GASTROENTEROLOGY (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
Ludovic Barault et al.
CANCER RESEARCH (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
M. Frattini et al.
BRITISH JOURNAL OF CANCER (2007)
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil - Based chemotherapy
Lanlan Shen et al.
CLINICAL CANCER RESEARCH (2007)
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene
Claudia I. Mueller et al.
LEUKEMIA RESEARCH (2007)
Detection of BRAF V600E mutation in colorectal cancer:: Comparison of automatic sequencing and real-time chemistry methodology
Susana Benlloch et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Low folate levels may protect against colorectal cancer
B. Van Guelpen et al.
GUT (2006)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Oncogenic PI3K and its role in cancer
Y Samuels et al.
CURRENT OPINION IN ONCOLOGY (2006)
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer
WS Samowitz et al.
GASTROENTEROLOGY (2005)
Low microsatellite instability is associated with poor prognosis in stage C colon cancer
MRJ Kohonen-Corish et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma
CM Wright et al.
GUT (2005)
Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability
RL Ward et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions
G Hallmans et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2003)
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
R Gryfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
